2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Intermediate Uveitis: new trials by email Literature Review of Intermediate Uveitis trials Research Report on Intermediate Uveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis Sham Injection, FAI Insert - Posterior Uveitis, Intermediate Uveitis | Phase 3 | Completed | EyePoint Pharmaceuticals, Inc. | 153 | 2015-06-02 | 2020-07-21 |
| A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis Dexamethasone, dexamethasone, Sham injection - Intermediate Uveitis, Posterior Uveitis | Phase 2 / Phase 3 | Completed | Allergan | 229 | 2006-05-01 | 2011-04-14 |
Uveitis, Intermediate (2) · Uveitis, Posterior (2) · Panuveitis (1)
Eye Diseases (2) · Uveal Diseases (2) · Uveitis (2) · Panuveitis (1)
salicylhydroxamic acid (2) · Dexamethasone (1) · Fluocinolone Acetonide (1)
Allergan (1) · EyePoint Pharmaceuticals, Inc. (1)
India (2) · Australia (1) · Austria (1) · Brazil (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · Israel (1) · Poland (1) · Portugal (1) · South Africa (1) · South Korea (1) · Spain (1)